Efficacy of Oxaliplatin-and 5-Fluorouracil-based Chemotherapy followed by Gastric Surgery in Advance

来源 :第十届中国医师协会外科医师年会 | 被引量 : 0次 | 上传用户:icesoul8585
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Background and Objectives To assess the efficacy and safety of oxaliplatin-and 5-fluorouracil(5-FU)-based preoperative chemotherapy regimensin advanced gastric adenocarcinoma and to identify the factors affecting remission and survival.Methods We retrospectively evaluated the following in 85 patients with advanced gastric adenocarcinoma who underwent surgical treatment after chemotherapy with oxaliplatin-and 5-FU: chemotherapy response,type of surgical resection,pretreatment clinical stage,TNM stage,tumor size,tumor differentiation status,and patient survival.Results Each patient received 2-6 cycles of preoperative chemotherapy; 5 patients(5.9%)achieved complete remission,42(49.4%)achieved partial remission,33(38.3%)had stable disease,and 5(5.9%)had progressive disease.The response rate was 55.3%.The 3-year survival rate of the 55 patients who underwent curative gastrectomy before 2014 was 61.8%,with a median overall survival of 32.4 months and a progression-free survival of 29.7 months.TNM stage(pretreatment stage,depth of tumor invasion,lymph node metastases,distant metastasis,and pathological stage),differentiation status,tumor size,and preoperative chemotherapy response were significantly associated with patient prognosis(P < 0.05).Conclusion TNM stage,tumor size,and tumor differentiation were associated with preoperative chemotherapy response and prognosis.Preoperative chemotherapy with surgery improves the prognosis of patients with gastric adenocarcinoma.
其他文献
目的:探究磷脂酶Cε1(PLCE1)在肝细胞癌组织中的表达及其对预后的预测价值.方法:应用免疫组化法研究90例肝细胞癌组织和相对应的癌旁组织中PLCE1的表达,并用qRT-PCR法和Western blot法检测其中20例肝细胞癌手术切除的癌组织和癌旁组织中PLCE1的表达,根据免疫组化结果分析PLCE1的表达与肝细胞癌临床病理特征和术后生存率的关系.结果:qRT-PCR实验和Western bl
目的:研究NVP-BEZ235在体外对胆管癌细胞株QBC939增殖及凋亡的影响,并探讨其可能的机制.方法:在体外培养人胆管癌细胞株QBC939,用流式细胞仪检测NVP-BEZ235对胆管癌细胞株的凋亡情况,MTT法检测NVP-BEZ235对胆管癌细胞株的增殖抑制作用;Western blotting分析NVP-BEZ235对胆管癌细胞株内PARP、Akt、p-Akt、Mcl-1、cFLIPL、Bc
目的:探讨原发性胃腺鳞癌的临床病理特征及诊断、治疗、预后的特点.方法:回顾性分析天津医科大学肿瘤医院2001年1月至2011年1月期间收治的42例原发性胃腺鳞癌患者临床、病理及随访资料.结果:本组患者1年、3年、5年生存率分别为82.2%、42.3%及18.2%.单因素分析结果显示,肿瘤最大直径、Borrmann分型、肿瘤分化程度、手术根治程度、是否有淋巴结转移及临床分期与患者预后有关(P<0.0
乳腺癌并发第二原发甲状腺癌分为同时性诊断和异时性诊断,乳腺癌可为甲状腺癌发生发展的高危因素,并增加甲状腺癌的发病率,但乳腺癌的第二原发癌的部位不局限于甲状腺,第二原发甲状腺癌具有其独特的临床病理特点,目前乳腺癌并发第二原发甲状腺癌的发病机制尚未阐明,其中激素、激素相关受体、基因易感性、治疗相关影响研究较多,治疗方式仍主要参考各自指南,基于目前乳腺癌并发第二原发甲状腺癌的风险增加,须加强乳腺癌患者甲
AIM A systematic review of the literature was performed to evaluate the quality of the current body of evidence on transanal total mesorectal excision(TaTME).METHODS MEDLINE,PubMed,EMBASE,Google Schol
Retroperitoneal liposarcoma is a rare malignant tumor and mostly diagnosed at a late stage.Surgery is the definitive treatment.In this report we present a rare giant liposarcoma(weigh 20.1kg in total)
会议
LncRNA是指长度在200-100000个核苷酸序列,其在基因表达调控过程中起重要作用,包括转录水平及转录后水平的表达调控.近年来,国内外研究发现多种LncRNA在胃癌的发生、发展过程中起作用,其中异常表达的LncRNA有望成为胃癌临床诊断的标记物和胃癌术后复查、监测的靶向指标.本文综述近5年研究胃癌中LncRNA表达情况的相关文献,探讨LncRNA在胃癌发生、发展中的作用机制.
目的:调查外科肝癌患者的营养状态、人体组成和能量代谢,并分析其相关性.方法:因原发性肝癌在外科住院拟行手术治疗的患者112例为研究组,对照组为同期因胆囊良性疾病拟接受手术治疗的100例患者;测量体重指数、上臂围和握力,外周血白蛋白和前白蛋白等,应用PG-SGA评定其营养状态;进行生物电阻抗人体组分测定和间接能量测定;并分析营养状态与人体组成和能量代谢的相关性.结果:与胆囊手术组比较,肝癌手术组患者
Purpose Our study aimed to help establish the standard of the minimum number of lymph nodes examined for rectal cancer,by estimating the probability that a pathologically node-negative patients has,in